Tobacco Use Treatment in Cancer Care (PCC SPOC)

Originally presented November 13, 2019, as part of the UNC Cancer Network RN and Allied Health Lecture Series. This Self-Paced, Online Course expires December 10, 2021. 

Presenter

Ellen Ruebush, LCSW, LCAS, NCTTP

Ellen Ruebush, LCSW, LCAS, NCTTP
Tobacco Treatment Specialist
Tobacco Treatment Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Colleen Meyer, MSW, LCSW

Colleen Meyer, MSW, LCSW
Tobacco Treatment Specialist
Tobacco Treatment Program
UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

Tobacco Use Treatment in Cancer Care

Patients who stop using tobacco have improved cancer treatment outcomes and decreased treatment-related side effects, making tobacco use treatment an essential component of cancer care. This lecture will present evidence-based treatment for tobacco use, including guidelines for brief intervention and for prescribing tobacco cessation medications.

Learning Outcomes

  • Describe evidence based brief behavioral interventions for tobacco use treatment.
  • Identify standard of care cessation medications and make appropriate recommendations.
  • Recognize special considerations for providing tobacco use treatment to oncology patients.

Credits Offered

  • 1.0 ANCC (CNE) hours of study
  • 1.0 ACPE hours of study
  • 1.0 ASRT Category A CE Credit
  • General Participation

Requirements

To receive credit for this course, you must:

  1. Watch a lecture video recording.
  2. Complete the lecture post test and obtain a passing score of 80% or higher.
  3. Complete the course evaluation.
  4. Select credit type.

Estimated course completion time: 1 hour

Disclosures

This activity has been planned and implemented under the sole supervision of the course directors, in association with the UNC Office of Continuing Professional Development (UNC CPD). Dr. Thomas Shea consults for Spectrum Pharma and receives research support from Millennium, Otsuka, GSK, BMS, Novartis and Seattle Genetics. Dr. James Coghill, MD, and CPD staff have no relevant financial relationships with commercial interests as defined by the ACCME.

The presenters, Ellen Ruebush, LCSW, LCAS, NCTTP, and Colleen Meyer, MSW, LCSW, have no conflicts of interest relevant to this presentation.

Accreditation

The School of Nursing at the University of North Carolina at Chapel Hill is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Approved by the UNC Eshelman School of Pharmacy for ACPE.

Approved by the American Society of Radiologic Technologists (ASRT).